Gritstone bio, Inc.
Gritstone bio, Inc. (GRTS) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
grts · stock forecast · 13 analysts (3M) · FMP · updated Nov 10, 2025
Analyst Rating & Consensus
Based on 13 Wall Street analysts in the past 3 months
Buy
13 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$6.00
Consensus
$4.67
+18505.6% upside
Low
$3.00
Median: $5 · Last Close: $0.03
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.03 | ↑ 3.09% |
1-day model range: $0.03–$0.03. Peak: $0.03 (+3.09%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · GRTS · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-10-02 | B. Riley Securities | Downgrade ↓ | Buy→Neutral |
| 2024-10-02 | Jones Trading | Downgrade ↓ | Buy→Hold |
| 2024-10-01 | JMP Securities | Downgrade ↓ | Market Outperform→Market Perform |
| 2024-10-01 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2024-08-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-05 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2024-08-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-06-14 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2024-05-24 | B. Riley Securities | Maintains | Buy→Buy |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Gritstone bio, Inc. (GRTS) stock. Of the recent 44 rating actions, 0 were upgrades and 8 were downgrades. 13 analysts currently cover GRTS.
Analyst Recommendation Trends
GRTS analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$9M
↓ 73.4% YoY
Revenue Next Year
$10M
↑ 7.5% YoY
EPS This Year
$-0.84
EPS Next Year
$-0.77
↓ 8.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast GRTS EPS of $-0.84 for the current fiscal year, based on estimates from 1 analysts. The GRTS revenue forecast is $9M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The GRTS stock forecast is supported by two independent data sources: analyst consensus ratings from 13 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus GRTS price target is $4.67 (+18505.6% upside), with an analyst consensus of Buy.
The GRTS short-term stock prediction for tomorrow is $0.03 (+3.09%).
Gritstone bio, Inc. trades on NASDAQ under the ticker GRTS. The GRTS stock outlook for 2027 is broadly positive, supported by a Buy consensus among 54% of covering analysts.
Frequently asked questions
GRTS forecast · 8 questionsAccording to 13 Wall Street analysts, the average 12-month GRTS price target is $4.67, with a high forecast of $6.00 and a low of $3.00. The median price target is shown in the chart above when available. This implies +18505.6% potential upside from the current price of $0.03.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.